Japanese
Secretariat
c/o Congress Corporation
3-6-13 Awajimachi, Chuo-ku,
Osaka 541-0047, Japan
Phone: +81-6-6229-2555
Fax: +81-6-6229-2556
E-mail: stroke2018@congre.co.jp

Welcome Message

会長 鈴木 倫保
Congress President, The 47th Annual Meeting of Japanese Society on Surgery for Cerebral Stroke
Hiroyuki Kinouchi, M.D., Ph.D.
Professor and Chairman, Department of Neurosurgery,
Yamanashi University, Faculty of Medicine

The 47th Annual Meeting of Japanese Society on Surgery for Cerebral Stroke will be held on March 15 (Thursday) to 18 (Sunday), 2018 in Fukuoka, Japan. Sharing the common title “Stroke 2018,” we will join with the 43rd Annual Meeting of Japan Stroke Society (president: Michiyasu Suzuki, Professor, Department of Neurosurgery, Yamaguchi University) and the 34th Spasm Symposium (president: Tatsuya Sasaki, Deputy Director, Aomori Prefectural Central Hospital).

Nearly half a century ago, in 1972, our first meeting was held under the name of the Japanese Conference on Surgery of Cerebral Stroke, at Sakunami Onsen in Sendai, Japan. Since then, surgical treatment for cerebral stroke has been making steady progress thanks to the constant efforts of our many predecessors and current members. The safety and security of surgical treatment has improved dramatically through the development of new therapeutic strategies based on neurological sciences, the introduction of advanced medical devices, including surgical microscopes, endoscopes, and monitoring systems, and the constant efforts of surgeons to acquire new surgical techniques, and to improve their skills by using such devices. Meanwhile, the situation related to cerebral stroke surgery is also changing. In Japan, the mode of onset, severity, and other pathologic aspects of cerebral stroke have been changing greatly due to the rapid aging of the population and the westernization of our diet and lifestyle. Accordingly, the clinical practice for cerebral stroke is also changing. New approaches to drug discovery by integrating medicine, pharmaceutics and engineering, as well as developments in medical technology, have increased the options of internal medical treatment and created a new field of cerebral endovascular treatment. This has now evolved from a supplementary treatment to a standard treatment, and greatly reduces the invasiveness of treatment while increasing the diversification of treatment. Furthermore, there have been many technical innovations in surgical treatment since the turn of this century. For example, the cerebral angiography system equipped with a multi-joint robotic arm is expected to play a key role in the near future as it visualizes the progress of surgical operations in real time and has led to a new therapeutic modality that combines surgery with endovascular treatment.

In view of this situation, and in line with the common theme for Stroke 2018 of “Understanding, Treating & Relieving Stroke: Mapping the Future,” we have set the main theme of our meeting as “Desired Innovations in Cerebral Stroke Surgery.” I would like to focus on the future of cerebral stroke surgery. I hope this meeting will provide good opportunities for thinking about our present role and future direction, while verifying the surgical treatments for cerebral stroke that are already widely used in Japan.

Accordingly, joint symposiums titled “Carotid Stenosis” and “Intracranial Aneurysm Stenosis” will be held in collaboration with the Japan Stroke Society. In addition, there will be a special program based on the results of a nationwide questionnaire survey and expert opinions on the present state in Japan, under the title of “Treatment of Internal Carotid Aneurysms in the Era of Flow Diverters.” Eight other symposiums will also be held under the titles of “Therapeutic Results for Subarachnoid Hemorrhage,” “Therapeutic Strategy for AVM,” “Partially Thrombotic Cerebral Aneurysms,” “Dissecting Aneurysms,” “Moyamoya Disease,” “Brain Stem Lesions,” “Craniocervical Junction Arteriovenous Fistula,” “Asymptomatic Diseases,” “Intraoperative Troubleshooting,” and “The True Value of Hybrid Surgery.” I hope these programs will provide new insights into the frontiers of cerebrovascular surgery.

Another major objective of this meeting is to develop human resources who will play key roles in the new era. Some sessions will allow their participants to gain basic and applied surgical techniques. Nine seminars with 25 sessions will be provided in the form of educational video seminars on surgical strategies, tactics, and practical techniques and tips, including surgical approaches, cerebral aneurysm clipping, AVM embolization and resection, hematoma evacuation, vascular anastomosis, deep bypass surgery, and CEA/CAS and other revascularization surgeries.

In addition, we will hear lectures by six experts from outside Japan. Dr. Michael T. Lawton from UCSF will talk about difficult surgical operations for aneurysms. Dr. Atul Goel from KEM Hospital in Mumbai will explain AVM treatment based on his extensive experience.
Dr. Jizong Zhao from Beijing Tiantan Hospital will describe the utility of hybrid surgery for intractable vascular disorders. Dr. Jin-Yang Joo from Yonsei University in Korea will talk about surgical treatment for cerebral aneurysms in view of the present status in Korea. Other lectures include surgical treatment for hemorrhage-onset cases of moyamoya disease described by Dr. Pil-Woo Huh from Catholic University Ujieongbu St. Mary’s Hospital, and surgical treatment for acute cerebral ischemia by Dr. Sung Don Kang from Wonkwang University. You are encouraged to learn the latest aspects of surgical treatment for cerebral stroke.

I greatly thank everyone involved for making as many as 830 presentations possible. I look forward to lively discussions and hope this meeting will be fruitful for all participants.

Along with all members of my laboratory, we look forward to welcoming you to Fukuoka.

Page Top